Sumioka I, Matsura T, Yamada K
Healthcare Research Institute, Wakunaga Pharmaceutical Co., Ltd., 1624 Shimokotachi, Koda-cho, Takata-gun, Hiroshima 739-1195, Japan.
Eur J Pharmacol. 2001 Dec 21;433(2-3):177-85. doi: 10.1016/s0014-2999(01)01503-5.
S-allylmercaptocysteine is one of the water-soluble organosulfur compounds in ethanol extracts of garlic (Allium sativum L.). We had demonstrated earlier that treatment with S-allylmercaptocysteine before acetaminophen administration protects mice against acetaminophen-induced hepatotoxicity. In this study, we examined the therapeutic effect of S-allylmercaptocysteine treatment after acetaminophen administration. A single dose of S-allylmercaptocysteine (200 mg/kg, p.o.) to mice 0.5 h after acetaminophen administration (500 mg/kg, p.o.) significantly suppressed both the increase in plasma alanine aminotransferase activity and the hepatic necrosis, and also reduced acetaminophen-induced mortality from 43% to 0%. These data indicate that S-allylmercaptocysteine is useful as an antidote for acetaminophen overdose. S-allylmercaptocysteine significantly suppressed hepatic cytochrome P450 2E1 (CYP2E1) activity and induction of inducible 70-kDa heat shock protein, a marker of acetaminophen arylation of protein. These results suggest that S-allylmercaptocysteine exerts its protective effect by inhibition of CYP2E1 activity, which leads to the suppression of acetaminophen arylation of hepatic protein.
S-烯丙基巯基半胱氨酸是大蒜(葱属植物)乙醇提取物中的水溶性有机硫化合物之一。我们之前已经证明,在给予对乙酰氨基酚之前用S-烯丙基巯基半胱氨酸处理可保护小鼠免受对乙酰氨基酚诱导的肝毒性。在本研究中,我们研究了对乙酰氨基酚给药后S-烯丙基巯基半胱氨酸治疗的效果。在对乙酰氨基酚(500mg/kg,口服)给药后0.5小时给小鼠单次剂量的S-烯丙基巯基半胱氨酸(200mg/kg,口服),可显著抑制血浆丙氨酸转氨酶活性的升高和肝坏死,并且还将对乙酰氨基酚诱导的死亡率从43%降低至0%。这些数据表明,S-烯丙基巯基半胱氨酸可用作对乙酰氨基酚过量的解毒剂。S-烯丙基巯基半胱氨酸显著抑制肝细胞色素P450 2E1(CYP2E1)活性以及诱导型70-kDa热休克蛋白的诱导,后者是对乙酰氨基酚蛋白质芳基化的标志物。这些结果表明,S-烯丙基巯基半胱氨酸通过抑制CYP2E1活性发挥其保护作用,这导致对乙酰氨基酚肝蛋白芳基化的抑制。